This document is an excerpt from the EUR-Lex website
Document 62020TA0679
Case T-679/20: Judgment of the General Court of 30 April 2025 – Dr. August Wolff v EUIPO – Combe International (Vagisan) (EU trade mark – Invalidity proceedings – International registration designating the European Union – Word mark Vagisan – Earlier national word marks VAGISIL – Relative ground for invalidity – Likelihood of confusion – Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009 (now Article 8(1)(b) and Article 60(1)(a) of Regulation (EU) 2017/1001) – Agreement on the withdrawal of the United Kingdom from the European Union and from Euratom – End of the transition period during the court proceedings)
Case T-679/20: Judgment of the General Court of 30 April 2025 – Dr. August Wolff v EUIPO – Combe International (Vagisan) (EU trade mark – Invalidity proceedings – International registration designating the European Union – Word mark Vagisan – Earlier national word marks VAGISIL – Relative ground for invalidity – Likelihood of confusion – Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009 (now Article 8(1)(b) and Article 60(1)(a) of Regulation (EU) 2017/1001) – Agreement on the withdrawal of the United Kingdom from the European Union and from Euratom – End of the transition period during the court proceedings)
Case T-679/20: Judgment of the General Court of 30 April 2025 – Dr. August Wolff v EUIPO – Combe International (Vagisan) (EU trade mark – Invalidity proceedings – International registration designating the European Union – Word mark Vagisan – Earlier national word marks VAGISIL – Relative ground for invalidity – Likelihood of confusion – Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009 (now Article 8(1)(b) and Article 60(1)(a) of Regulation (EU) 2017/1001) – Agreement on the withdrawal of the United Kingdom from the European Union and from Euratom – End of the transition period during the court proceedings)
OJ C, C/2025/3274, 24.6.2025, ELI: http://data.europa.eu/eli/C/2025/3274/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN C series |
|
C/2025/3274 |
24.6.2025 |
Judgment of the General Court of 30 April 2025 – Dr. August Wolff v EUIPO – Combe International (Vagisan)
(Case T-679/20) (1)
(EU trade mark - Invalidity proceedings - International registration designating the European Union - Word mark Vagisan - Earlier national word marks VAGISIL - Relative ground for invalidity - Likelihood of confusion - Article 8(1)(b) and Article 53(1)(a) of Regulation (EC) No 207/2009 (now Article 8(1)(b) and Article 60(1)(a) of Regulation (EU) 2017/1001) - Agreement on the withdrawal of the United Kingdom from the European Union and from Euratom - End of the transition period during the court proceedings)
(C/2025/3274)
Language of the case: English
Parties
Applicant: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany) (represented by: M. Breuer and F. von der Decken, lawyers)
Defendant: European Union Intellectual Property Office (represented by: D. Gája and V. Ruzek, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Combe International LLC (New York, New York, United States) (represented by: M. Kinkeldey, S. Brandstätter and S. Clotten, lawyers)
Re:
By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 3 September 2020 (Case R 2459/2019-4).
Operative part of the judgment
The Court:
|
1. |
Dismisses the application for a declaration that there is no need to adjudicate; |
|
2. |
Dismisses the action; |
|
3. |
Orders Dr. August Wolff GmbH & Co. KG Arzneimittel to pay the costs. |
ELI: http://data.europa.eu/eli/C/2025/3274/oj
ISSN 1977-091X (electronic edition)